PHATHOM PHARMACEUTICALS INC (PHAT) Stock Earnings & Estimates
NASDAQ:PHAT - US71722W1071 - Common Stock
12.34 USD
+0.34 (+2.83%)
12.34 USD
0 (0%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 682K | 55.252M 8,001.47% | 169.91M 207.52% | 333.81M 96.46% | 516.45M 54.71% | 734.37M 42.20% | 890.54M 21.27% | 1.028B 15.44% | 1.147B 11.58% | 1.246B 8.63% | ||
| EBITDA YoY % growth | -171.82M -27.69% | -166.737M 2.96% | -276.672M -65.93% | -168.873M 38.96% | 41.497M 124.57% | 229.42M 452.86% | 427.89M 86.51% | 563.47M 31.69% | 632.79M 12.30% | 727.25M 14.93% | 759.95M 4.50% | |
| EBIT YoY % growth | -172.44M -27.66% | -167.312M 2.97% | -277.467M -65.84% | -187.024M 32.60% | -9.506M 94.92% | 139.58M 1,568.38% | 331.11M 137.22% | 442.92M 33.77% | 521.75M 17.80% | 609.57M 16.83% | 665.1M 9.11% | |
| Operating Margin | N/A | -24,532.55% | -502.18% | -110.07% | -2.85% | 27.03% | 45.09% | 49.74% | 50.75% | 53.14% | 53.38% | |
| EPS YoY % growth | -5.05 -29.82% | -3.88 23.17% | -5.35 -37.89% | -3.48 34.99% | -0.83 76.04% | 1.33 259.09% | 3.98 200.00% | 5.31 33.51% | 6.35 19.65% | 8.07 27.05% | 8.74 8.28% |
All data in USD
| Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.57 57.11% | -0.38 63.41% | -0.48 63.40% | -0.33 68.43% | -0.16 72.37% | -0.04 90.26% |
| Revenue Q2Q % growth | 47.438M 190.11% | 56.646M 90.96% | 57.364M 101.14% | 72.824M 84.35% | 82.493M 73.90% | 99.348M 75.38% |
| EBITDA Q2Q % growth | -16.966M 75.83% | -4.092M 93.02% | -5.916M 92.48% | 3.264M 105.48% | 11.118M 165.53% | 34.68M 947.56% |
| EBIT Q2Q % growth | -25.47M 64.02% | -12.07M 79.69% | -14.681M 81.38% | -3.93M 93.44% | 5.984M 123.49% | 20.366M 268.73% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | -1.05 32.69% | -1.06 | 0.01 | 1.02% |
| Q1 2025 Q2Q % growth | -1.31 7.75% | -1.17 | -0.14 | -12.00% |
| Q4 2024 Q2Q % growth | -1.05 24.46% | -1.30 | 0.25 | 19.05% |
| Q3 2024 Q2Q % growth | -1.32 -73.68% | -1.52 | 0.20 | 13.44% |
| Q2 2024 Q2Q % growth | -1.56 -85.71% | -1.41 | -0.15 | -10.83% |
| Q1 2024 Q2Q % growth | -1.42 -59.55% | -1.34 | -0.08 | -6.34% |
| Q4 2023 Q2Q % growth | -1.39 -4.51% | -1.10 | -0.29 | -26.53% |
| Q3 2023 Q2Q % growth | -0.76 42.42% | -0.91 | 0.15 | 16.42% |
| Q2 2023 Q2Q % growth | -0.84 36.84% | -1.00 | 0.16 | 15.84% |
| Q1 2023 Q2Q % growth | -0.89 16.82% | -1.29 | 0.40 | 30.78% |
| Q4 2022 Q2Q % growth | -1.33 -40.00% | -1.38 | 0.05 | 3.53% |
| Q3 2022 Q2Q % growth | -1.32 -34.69% | -1.34 | 0.02 | 1.79% |
| Q2 2022 Q2Q % growth | -1.33 -33.00% | -1.05 | -0.28 | -26.59% |
| Q1 2022 Q2Q % growth | -1.07 -11.46% | -0.99 | -0.08 | -8.37% |
| Q4 2021 Q2Q % growth | -0.95 39.87% | -1.05 | 0.10 | 9.43% |
| Q3 2021 Q2Q % growth | -0.98 3.92% | -1.00 | 0.02 | 1.96% |
| Q2 2021 Q2Q % growth | -1.00 -56.25% | -1.09 | 0.09 | 8.23% |
| Q1 2021 Q2Q % growth | -0.96 -54.84% | -1.21 | 0.25 | 20.80% |
| Q4 2020 Q2Q % growth | -1.58 60.20% | -1.03 | -0.55 | -53.12% |
| Q3 2020 Q2Q % growth | -1.02 89.03% | -0.69 | -0.33 | -48.52% |
| Q2 2020 Q2Q % growth | -0.64 | -0.57 | -0.07 | -12.04% |
| Q1 2020 Q2Q % growth | -0.62 | -0.73 | 0.11 | 15.19% |
| Q4 2019 Q2Q % growth | -3.97 | -1.28 | -2.70 | -211.37% |
| Q3 2019 Q2Q % growth | -9.30 | -1.16 | -8.14 | -699.79% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | 39.503M 439.36% | 36.798M | 2.705M | 7.35% |
| Q1 2025 Q2Q % growth | 28.519M 1,391.58% | 29.596M | -1.077M | -3.64% |
| Q4 2024 Q2Q % growth | 29.664M 4,249.56% | 25.408M | 4.256M | 16.75% |
| Q3 2024 Q2Q % growth | 16.352M | 12.861M | 3.491M | 27.14% |
| Q2 2024 Q2Q % growth | 7.324M | 5.925M | 1.399M | 23.61% |
| Q1 2024 Q2Q % growth | 1.912M | 2.088M | -176K | -8.43% |
| Q4 2023 Q2Q % growth | 682K | 420.577K | 261.423K | 62.16% |
| Q3 2022 Q2Q % growth | 204K | -204K | -100.00% | |
| Q1 2022 Q2Q % growth | 215.22K | -215.22K | -100.00% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 14.83% | 44.64% | 1.4% | 7.84% |
| Revenue | 7.87% | -1.08% | 4.46% | 4.09% |